The Chinese health food and supplements market is valued at US$30 billion and projected to grow by 10% every year until 2025, creating extensive opportunities for Australian firms, writes Carl Gibson, CEO of Complementary Medicines Australia.
Professional consumers are continuing to plague international firms in China by lodging complaints over minor regulatory breaches in the hope of being awarded compensation.
Blackmores’ standing in China has received a boost after its Asia MD, Peter Osborne, was appointed vice chairman of the China Association for Quality Inspection’s (CAQI) advisory committee.
Whey protein, enzymes and collagen products take the top three spots in China’s cross-border e-commerce sales, according to the international director of Ali Health, part of the Alibaba group.
Steady demand for Australian health products has prompted Melbourne-based probiotics specialist Evolution Health to invest heavily in China, with the firm now eyeing greater global expansion.
China’s infant milk formula market is poised to boom in the next five years as a result of the new “two-child” policy, and tighter rules issued by regulators, analysts said today.
Blackmores CEO Christine Holgate has gone on a charm offensive in China, highlighting the company’s and Australia’s growing ties with the country in terms of both trade and product development.
Companies seeking to launch products in China have been told they have to be in it for long haul and make extensive preparations, ‘instead of turning up at Shanghai airport and asking trade officials for a list of distributors’.
Vitamins manufacturer Blackmores was fined AUS$65,000 (US$50,000), and publicly named and shamed by authorities in China for breaching strict advertising laws.
China’s ageing population has poorer cognitive and physical function compared with their counterparts from 10 years ago, according to the largest study of its kind, published in The Lancet.
A new systematic re-analysis of prenatal exposure to the Great Chinese Famine of 1959-61 suggests that schizophrenia may have been the leading health consequence.
Net profits at supplements manufacturer Blackmores slumped by 42% in the first of half of the financial year, with the firm reporting reduced demand from Chinese ‘daigou’ shoppers who buy in Australia and then ship goods back to their homeland.
A Chinese company called Ideal Health Biotechnology has joined a raft of businesses from that country in relocating to the US to gain a ‘made in USA’ positioning.
Five universities have joined forces to establish a joint knowledge base for international food companies to access the Chinese market, and promote their food science and nutrition work in the country.
With more than 100 infant milk powder manufacturers established and thousands of product lines launched in the last 30 years, overcrowding in the segment appears to have hit Chinese businesses hard.
China has provided one of the few positive notes in Mead Johnson’s quarterly results, with bosses hailing “substantial progress” in the country, despite conceding that global growth would be slower than planned.
Net profits at Australian vitamin and supplement supplier Blackmores fell by 46.6% in the first quarter, with daigou sales – items bought by Chinese entrepreneurs in Australia to ship back to China – plummeting.
China may have opened up its economy even more in the last several years but it's not as if the floodgates are wide apart. Much of this "openness" is actually born out of necessity rather than a love of equity. It's foreign trade policies...
Omega-3 trade body GOED is entering a partnership with the US-China Health Products Association (US-CHPA) to better serve its member companies in the Chinese market.
The U.S.-China Health Products Association (USCHPA) is staging a free seminar at next week’s SupplySide West show to provide the lowdown on the latest regulatory changes in China’s nutritional ingredients and dietary supplements market.
The rise of China’s functional food and dietary supplement industry is continuing to outstrip overall economic growth, and will continue to do so with sports nutrition and goods for the elderly likely to drive future increases.
New Zealand’s a2 Milk Company has signalled its intention to branch out from infant formula into a broader range of dairy-based nutritional products – with the burgeoning China market very much in its sights.
Strong demand for healthcare products and growing recognition of overseas brands is driving more Chinese companies to find overseas corporate targets, according to market intelligence provider CCM.
Health experts in China have defended iron-fortified soy sauce as an effective and safe way to reduce anemia after claims emerged that it could cause cancer and other health problems.
Chinese regulators are developing standards for bovine colostrum,
the first milk from cows that has a growing following as a health
product among Chinese consumers.